Do analysts recommend BRTX or ATPC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Biorestorative Therapies 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Agape ATP 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts recommend ACON or ATPC?

Aclarion currently has a consensus price target of $7.50, suggesting a potential upside of 217.80%. Given Aclarion's stronger consensus rating and higher possible upside, equities analysts plainly believe Aclarion is more favorable than Agape ATP. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aclarion 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Agape ATP 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better valuation and earnings, ACON or ATPC?

Agape ATP has higher revenue and earnings than Aclarion. Agape ATP is trading at a lower price-to-earnings ratio than Aclarion, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Aclarion $80K 72.57 -$7.23M -$9.03 N/A Agape ATP $1.52M 1.53 -$2.28M -$1.33 N/A

Is ACON or ATPC more profitable?

Agape ATP has a net margin of -125.89% compared to Aclarion's net margin of -10,320.51%. Agape ATP's return on equity of -8.43% beat Aclarion's return on equity. Company Net Margins Return on Equity Return on Assets Aclarion -10,320.51% -54.41% -51.71% Agape ATP -125.89% -8.43% -7.75%

Does the media favor ACON or ATPC?

In the previous week, Aclarion had 1 more articles in the media than Agape ATP. MarketBeat recorded 2 mentions for Aclarion and 1 mentions for Agape ATP. Aclarion's average media sentiment score of 0.42 beat Agape ATP's score of 0.00 indicating that Aclarion is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aclarion 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Agape ATP 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend BGLC or ATPC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BioNexus Gene Lab 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Agape ATP 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media favor BGLC or ATPC?

In the previous week, BioNexus Gene Lab and BioNexus Gene Lab both had 1 articles in the media. BioNexus Gene Lab's average media sentiment score of 0.00 equaled Agape ATP'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BioNexus Gene Lab 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Agape ATP 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate ATPC or NIVF?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Agape ATP 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 NewGenIvf Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better earnings and valuation, ATPC or NIVF?

NewGenIvf Group has higher revenue and earnings than Agape ATP. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Agape ATP $1.52M 1.53 -$2.28M -$1.33 N/A NewGenIvf Group $4.73M 0.47 $9.88M N/A N/A

Does the media refer more to ATPC or NIVF?

In the previous week, NewGenIvf Group had 3 more articles in the media than Agape ATP. MarketBeat recorded 4 mentions for NewGenIvf Group and 1 mentions for Agape ATP. NewGenIvf Group's average media sentiment score of 0.43 beat Agape ATP's score of 0.00 indicating that NewGenIvf Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Agape ATP 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral NewGenIvf Group 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate ATPC or DHAC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Agape ATP 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Digital Health Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has higher valuation and earnings, ATPC or DHAC?

Digital Health Acquisition has lower revenue, but higher earnings than Agape ATP. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Agape ATP $1.52M 1.53 -$2.28M -$1.33 N/A Digital Health Acquisition N/A N/A N/A N/A N/A

Agape ATP (ATPC) Competitors

$2.32 +0.01 (+0.43%)

Closing price 04:00 PM Eastern

Extended Trading

$2.40 +0.08 (+3.41%)

As of 07:47 PM Eastern

Compare

ATPC vs. BRTX, ACON, BGLC, NIVF, and DHAC

Should you buy Agape ATP stock or one of its competitors? MarketBeat compares Agape ATP with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Agape ATP include Biorestorative Therapies (BRTX), Aclarion (ACON), BioNexus Gene Lab (BGLC), NewGenIvf Group (NIVF), and Digital Health Acquisition (DHAC).

How does Agape ATP compare to Biorestorative Therapies?

Biorestorative Therapies (NASDAQ:BRTX) and Agape ATP (NASDAQ:ATPC) are related small-cap companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, institutional ownership, media sentiment, dividends, valuation and profitability.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biorestorative Therapies	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Agape ATP	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Agape ATP has higher revenue and earnings than Biorestorative Therapies. Agape ATP is trading at a lower price-to-earnings ratio than Biorestorative Therapies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biorestorative Therapies	$360K	14.01	-$14.24M	-$1.07	N/A
Agape ATP	$1.52M	1.53	-$2.28M	-$1.33	N/A

In the previous week, Agape ATP had 1 more articles in the media than Biorestorative Therapies. MarketBeat recorded 1 mentions for Agape ATP and 0 mentions for Biorestorative Therapies. Biorestorative Therapies' average media sentiment score of 0.00 equaled Agape ATP'saverage media sentiment score.

Company	Overall Sentiment
Biorestorative Therapies	Neutral
Agape ATP	Neutral

Biorestorative Therapies has a beta of 0.79, suggesting that its share price is 21% less volatile than the broader market. Comparatively, Agape ATP has a beta of 0.38, suggesting that its share price is 62% less volatile than the broader market.

69.4% of Biorestorative Therapies shares are held by institutional investors. Comparatively, 0.0% of Agape ATP shares are held by institutional investors. 13.6% of Biorestorative Therapies shares are held by company insiders. Comparatively, 2.0% of Agape ATP shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Agape ATP has a net margin of -125.89% compared to Biorestorative Therapies' net margin of -3,088.27%. Agape ATP's return on equity of -8.43% beat Biorestorative Therapies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Biorestorative Therapies	-3,088.27%	-508.42%	-230.94%
Agape ATP	-125.89%	-8.43%	-7.75%

Summary

Agape ATP beats Biorestorative Therapies on 6 of the 11 factors compared between the two stocks.

How does Agape ATP compare to Aclarion?

Aclarion (NASDAQ:ACON) and Agape ATP (NASDAQ:ATPC) are related small-cap companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, dividends, earnings, institutional ownership and profitability.

7.5% of Aclarion shares are held by institutional investors. Comparatively, 0.0% of Agape ATP shares are held by institutional investors. 0.0% of Aclarion shares are held by insiders. Comparatively, 2.0% of Agape ATP shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Aclarion had 1 more articles in the media than Agape ATP. MarketBeat recorded 2 mentions for Aclarion and 1 mentions for Agape ATP. Aclarion's average media sentiment score of 0.42 beat Agape ATP's score of 0.00 indicating that Aclarion is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aclarion	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Agape ATP	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Agape ATP has a net margin of -125.89% compared to Aclarion's net margin of -10,320.51%. Agape ATP's return on equity of -8.43% beat Aclarion's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aclarion	-10,320.51%	-54.41%	-51.71%
Agape ATP	-125.89%	-8.43%	-7.75%

Agape ATP has higher revenue and earnings than Aclarion. Agape ATP is trading at a lower price-to-earnings ratio than Aclarion, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aclarion	$80K	72.57	-$7.23M	-$9.03	N/A
Agape ATP	$1.52M	1.53	-$2.28M	-$1.33	N/A

Aclarion has a beta of 1.22, suggesting that its stock price is 22% more volatile than the broader market. Comparatively, Agape ATP has a beta of 0.38, suggesting that its stock price is 62% less volatile than the broader market.

Aclarion currently has a consensus price target of $7.50, suggesting a potential upside of 217.80%. Given Aclarion's stronger consensus rating and higher possible upside, equities analysts plainly believe Aclarion is more favorable than Agape ATP.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aclarion	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Agape ATP	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Aclarion beats Agape ATP on 8 of the 15 factors compared between the two stocks.

How does Agape ATP compare to BioNexus Gene Lab?

BioNexus Gene Lab (NASDAQ:BGLC) and Agape ATP (NASDAQ:ATPC) are related small-cap companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, earnings, institutional ownership, profitability, media sentiment and dividends.

BioNexus Gene Lab has a net margin of -54.70% compared to Agape ATP's net margin of -125.89%. Agape ATP's return on equity of -8.43% beat BioNexus Gene Lab's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BioNexus Gene Lab	-54.70%	-37.43%	-32.88%
Agape ATP	-125.89%	-8.43%	-7.75%

Agape ATP has lower revenue, but higher earnings than BioNexus Gene Lab. Agape ATP is trading at a lower price-to-earnings ratio than BioNexus Gene Lab, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BioNexus Gene Lab	$7.43M	0.47	-$2.98M	-$1.48	N/A
Agape ATP	$1.52M	1.53	-$2.28M	-$1.33	N/A

BioNexus Gene Lab has a beta of 4.17, suggesting that its stock price is 317% more volatile than the broader market. Comparatively, Agape ATP has a beta of 0.38, suggesting that its stock price is 62% less volatile than the broader market.

In the previous week, BioNexus Gene Lab and BioNexus Gene Lab both had 1 articles in the media. BioNexus Gene Lab's average media sentiment score of 0.00 equaled Agape ATP'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
BioNexus Gene Lab	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Agape ATP	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

18.9% of BioNexus Gene Lab shares are held by institutional investors. Comparatively, 0.0% of Agape ATP shares are held by institutional investors. 0.1% of BioNexus Gene Lab shares are held by company insiders. Comparatively, 2.0% of Agape ATP shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BioNexus Gene Lab	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Agape ATP	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Agape ATP beats BioNexus Gene Lab on 6 of the 11 factors compared between the two stocks.

How does Agape ATP compare to NewGenIvf Group?

Agape ATP (NASDAQ:ATPC) and NewGenIvf Group (NASDAQ:NIVF) are related small-cap companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, media sentiment, analyst recommendations, profitability, dividends, valuation and earnings.

NewGenIvf Group has higher revenue and earnings than Agape ATP.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Agape ATP	$1.52M	1.53	-$2.28M	-$1.33	N/A
NewGenIvf Group	$4.73M	0.47	$9.88M	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Agape ATP	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
NewGenIvf Group	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, NewGenIvf Group had 3 more articles in the media than Agape ATP. MarketBeat recorded 4 mentions for NewGenIvf Group and 1 mentions for Agape ATP. NewGenIvf Group's average media sentiment score of 0.43 beat Agape ATP's score of 0.00 indicating that NewGenIvf Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Agape ATP	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
NewGenIvf Group	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Agape ATP has a beta of 0.38, indicating that its stock price is 62% less volatile than the broader market. Comparatively, NewGenIvf Group has a beta of 0.01, indicating that its stock price is 99% less volatile than the broader market.

NewGenIvf Group has a net margin of 0.00% compared to Agape ATP's net margin of -125.89%. NewGenIvf Group's return on equity of 0.00% beat Agape ATP's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Agape ATP	-125.89%	-8.43%	-7.75%
NewGenIvf Group	N/A	N/A	N/A

0.0% of Agape ATP shares are held by institutional investors. Comparatively, 66.2% of NewGenIvf Group shares are held by institutional investors. 2.0% of Agape ATP shares are held by company insiders. Comparatively, 31.8% of NewGenIvf Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

NewGenIvf Group beats Agape ATP on 9 of the 11 factors compared between the two stocks.

How does Agape ATP compare to Digital Health Acquisition?

Agape ATP (NASDAQ:ATPC) and Digital Health Acquisition (NASDAQ:DHAC) are related small-cap companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, risk, valuation, dividends, analyst recommendations, profitability, media sentiment and earnings.

0.0% of Agape ATP shares are held by institutional investors. Comparatively, 1.0% of Digital Health Acquisition shares are held by institutional investors. 2.0% of Agape ATP shares are held by company insiders. Comparatively, 6.6% of Digital Health Acquisition shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, Agape ATP had 1 more articles in the media than Digital Health Acquisition. MarketBeat recorded 1 mentions for Agape ATP and 0 mentions for Digital Health Acquisition. Agape ATP's average media sentiment score of 0.00 equaled Digital Health Acquisition'saverage media sentiment score.

Company	Overall Sentiment
Agape ATP	Neutral
Digital Health Acquisition	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Agape ATP	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Digital Health Acquisition	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Digital Health Acquisition has lower revenue, but higher earnings than Agape ATP.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Agape ATP	$1.52M	1.53	-$2.28M	-$1.33	N/A
Digital Health Acquisition	N/A	N/A	N/A	N/A	N/A

Agape ATP has a beta of 0.38, suggesting that its share price is 62% less volatile than the broader market. Comparatively, Digital Health Acquisition has a beta of 0.23, suggesting that its share price is 77% less volatile than the broader market.

Digital Health Acquisition has a net margin of 0.00% compared to Agape ATP's net margin of -125.89%. Digital Health Acquisition's return on equity of 0.00% beat Agape ATP's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Agape ATP	-125.89%	-8.43%	-7.75%
Digital Health Acquisition	N/A	N/A	N/A

Summary

Digital Health Acquisition beats Agape ATP on 5 of the 9 factors compared between the two stocks.

Get Agape ATP News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ATPC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ATPC vs. The Competition

Export

Metric	Agape ATP	Personal Care Products Industry	Consumer Staples Sector	NASDAQ Exchange
Market Cap	$2.31M	$22.80B	$16.15B	$12.68B
Dividend Yield	N/A	4.22%	3.20%	10.03%
P/E Ratio	-1.74	18.91	14.51	25.13
Price / Sales	1.53	12.86	262,948.57	93.66
Price / Cash	N/A	16.74	56.11	34.82
Price / Book	0.10	2.95	4.99	6.21
Net Income	-$2.28M	$1.08B	$841.31M	$347.49M
7 Day Performance	-4.13%	0.13%	0.94%	0.89%
1 Month Performance	-18.02%	-3.45%	-0.64%	-3.60%
1 Year Performance	-96.55%	-18.16%	13.00%	20.46%

Agape ATP Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ATPC Agape ATP	0.3612 of 5 stars	$2.32 +0.4%	N/A	-96.6%	$2.31M	$1.52M	N/A	40
BRTX Biorestorative Therapies	0.8478 of 5 stars	$0.25 -7.3%	N/A	-85.5%	$6.79M	$360K	N/A	7	Positive News High Trading Volume
ACON Aclarion	3.6522 of 5 stars	$2.02 -5.2%	$7.50 +271.3%	-67.8%	$5.24M	$80K	N/A	7	High Trading Volume
BGLC BioNexus Gene Lab	0.5479 of 5 stars	$1.36 +0.7%	N/A	-79.6%	$3.26M	$7.43M	N/A	30	Gap Down High Trading Volume
NIVF NewGenIvf Group	2.7226 of 5 stars	$0.85 -8.2%	N/A	-99.8%	$3.18M	$4.73M	N/A	N/A	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ATPC) was last updated on 8/3/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Agape ATP (ATPC) Competitors

ATPC vs. BRTX, ACON, BGLC, NIVF, and DHAC

How does Agape ATP compare to Biorestorative Therapies?

Summary

How does Agape ATP compare to Aclarion?

Summary

How does Agape ATP compare to BioNexus Gene Lab?

Summary

How does Agape ATP compare to NewGenIvf Group?

Summary

How does Agape ATP compare to Digital Health Acquisition?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ATPC vs. The Competition

Agape ATP Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Agape ATP (ATPC) Competitors

ATPC vs. BRTX, ACON, BGLC, NIVF, and DHAC

How does Agape ATP compare to Biorestorative Therapies?

Do analysts recommend BRTX or ATPC?

Which has stronger earnings and valuation, BRTX or ATPC?

Does the media prefer BRTX or ATPC?

Which has more risk & volatility, BRTX or ATPC?

Do insiders and institutionals hold more shares of BRTX or ATPC?

Is BRTX or ATPC more profitable?

Summary

How does Agape ATP compare to Aclarion?

Do insiders & institutionals hold more shares of ACON or ATPC?

Does the media favor ACON or ATPC?

Is ACON or ATPC more profitable?

Which has better valuation and earnings, ACON or ATPC?

Which has more volatility & risk, ACON or ATPC?

Do analysts recommend ACON or ATPC?

Summary

How does Agape ATP compare to BioNexus Gene Lab?

Is BGLC or ATPC more profitable?

Which has higher earnings & valuation, BGLC or ATPC?

Which has more volatility and risk, BGLC or ATPC?

Does the media favor BGLC or ATPC?

Do institutionals and insiders hold more shares of BGLC or ATPC?

Do analysts recommend BGLC or ATPC?

Summary

How does Agape ATP compare to NewGenIvf Group?

Which has better earnings and valuation, ATPC or NIVF?

Do analysts rate ATPC or NIVF?

Does the media refer more to ATPC or NIVF?

Which has more volatility and risk, ATPC or NIVF?

Is ATPC or NIVF more profitable?

Do institutionals & insiders have more ownership in ATPC or NIVF?

Summary

How does Agape ATP compare to Digital Health Acquisition?

Do institutionals and insiders have more ownership in ATPC or DHAC?

Does the media refer more to ATPC or DHAC?

Do analysts rate ATPC or DHAC?

Which has higher valuation and earnings, ATPC or DHAC?

Which has more risk & volatility, ATPC or DHAC?

Is ATPC or DHAC more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ATPC vs. The Competition

Agape ATP Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools